INSIGHTS ON DRUG DEVELOPMENT
-
Strategic Early Material Generation For Accelerated Process Development
Learn how early material generation strategies can accelerate biologics development, streamline process optimization, and enable scalable, production-relevant material supply from the earliest stages of development.
-
A Simple And Powerful Solution For Accelerating Dissolution
Many poorly soluble drugs fail not because of low solubility, but because they dissolve too slowly. Learn how focusing on dissolution rate can unlock absorption gains using simple strategies.
-
Studying The Spatial Architecture Of Glioblastoma
Explore how intra-tumor heterogeneity (ITH) impacts cancer progression and therapy resistance with advanced imaging platforms and custom antibody panels to reveal the spatial architecture of glioblastoma (GBM).
-
Direct qPCR Amplification From Human Urine Samples
Extraction-free qPCR enables faster, lower-cost detection of UTI-associated bacteria directly from urine samples. Explore how this approach simplifies workflows and accelerates time to results.
-
Looking Beyond Solubility And Process Performance9/2/2026
Solvent selection for spray-dried dispersions significantly impacts drug performance, scalability, and supply chains. Early, structured solvent choice is vital for successful manufacturing and commercialization.
-
Closing The QC Gap For mAbs: Rapid Answers Without Compromising6/9/2026
Monoclonal antibodies are complex biologics requiring precise analytical strategies to monitor critical quality attributes and impurities, with molecular assays like qPCR supporting sensitive detection, product integrity, and regulatory compliance.
-
How Lipid Nanoparticles Enable Next-Gen Delivery10/20/2025
Cell therapy’s future depends on smarter gene delivery. Learn how lipid nanoparticles offer a scalable, cell-friendly alternative to electroporation and viral vectors for manufacturing efficiency.
-
Dosage Form Scale-Up: Balancing Speed And Efficiency In Later-Stage Development9/22/2026
Reduce development risk and improve readiness for larger trials with strategies that align formulation, manufacturing, and commercialization goals.
-
Sterilization Of APIs – The Alternative: Sterile Filtration Following Aseptic Processing5/21/2026
When terminal sterilization isn't an option for heat- or radiation-sensitive APIs, sterile filtration with aseptic processing protects quality. Get the technical framework.
DRUG DEVELOPMENT SOLUTIONS
-
By harnessing cutting-edge microcalorimetry technology, researchers can unravel the complexities of molecular interactions, paving the way for groundbreaking discoveries in drug development.
-
Explore imaging, fluorescence, and luminescence-based techniques for cell analysis, viability, and gene expression, as well as how multimode readers streamline workflows and enhance data quality.
-
MaxPeak™ Premier Columns utilize MaxPeak High Performance Surfaces that are designed to increase analyte recovery, sensitivity, and reproducibility by minimizing analyte/surface interactions that can lead to sample losses.
-
Quickly address critical formulation issues and optimizing performance. Explore services for small molecules and synthetic peptides across oral, topical, rectal, and parenteral routes.
-
STELLARIS 8 CRS Coherent Raman Scattering Microscope
When you need to study structures that cannot be visualized with traditional fluorescent microscopy methods, the STELLARIS 8 Coherent Raman Scattering (CRS) microscope enables you to implement label-free chemical imaging into your workflow to answer those challenging research questions.